| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0009 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.002 |